Skip to main content
. Author manuscript; available in PMC: 2014 Sep 5.
Published in final edited form as: J Pediatr. 2013 Aug 2;163(5):1354–60.e1-7. doi: 10.1016/j.jpeds.2013.06.039

Table III. List of significant factors (P < 0.1) in univariate logistic regression for linear growth impairment at last follow-up visit.

Factor Comparison group Reference group OR CI P value Overall P value
Race Black White 1.27 (0.79, 2.02) .3213 .0009
Hispanic 1.79 (1.11, 2.90) .0172
Other 2.60 (1.57, 4.29) .0002
Primary diagnosis Other cholestatic Biliary atresia 3.84 (2.42, 6.11) <.0001 <.0001
Fulminant liver failure 0.38 (0.18, 0.80) .0105
Metabolic disease 1.68 (1.03, 2.73) .0359
Cirrhosis 1.45 (0.73, 2.88) .2929
Other 0.84 (0.42, 1.66) .6072
Patient status at transplant ICU Not hospitalized 0.59 (0.38, 0.92) .0209 .0488
Hospitalized, not in ICU 0.73 (0.44, 1.21) .2198
Nutrition intake at listing Intravenous Oral 0.72 (0.39, 1.34) .2999 .0102
Enteral (nasogastric tube) 1.87 (1.18, 2.96) .0072
Height failure at transplant Yes No 7.72 (5.17, 11.52) <.0001 <.0001
Special education prior to transplant Yes No 2.69 (1.49, 4.86) .0011 .0031
No education 1.06 (0.73, 1.53) .7661
Re-transplanted Yes No 2.35 (1.43, 3.87) .0008 .0008
Steroids at last height measurement Yes No 1.81 (1.24, 2.64) .0022 .0022
Albumin at 12 mo (g/dL) Continuous 0.70 (0.50, 0.98) - .0392
Log(INR) at transplant Continuous 0.59 (0.39, 0.89) - .0126
GGTat 12 mo (U/L) Continuous 1.001 1.000, 1.002 - .0031

ICU, intensive care unit.

Bold values indicate significant < .05.